International Stem Cell Corporation

About:

International Stem Cell Corp is a clinical stage biotechnology company with a powerful new stem cell technology called parthenogenesis.

Website: http://internationalstemcell.com

Twitter/X: intlstemcell

Description:

International Stem Cell Corporation (ISCO) is a publicly traded biotechnology company with a powerful new stem cell technology called parthenogenesis which uses unfertilized eggs, and promises to significantly advance the field of regenerative medicine by addressing the problem of immune-rejection. They are focused on using these stem cells to treat diseases of the eye, the nervous system and the liver, where cell therapy has been proven clinically yet is limited by the availability of safe immune-matched human cells or tissue.

Total Funding Amount:

$7.5M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Carlsbad, California, United States

Founded Date:

2001-01-01

Contact Email:

ir(AT)intlstemcell.com

Founders:

William B. Adams

Number of Employees:

11-50

Last Funding Date:

2014-10-23

IPO Status:

Public

Industries:

© 2025 bioDAO.ai